Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TELO

Telomir Pharmaceuticals Inc

Apr 29 • 04:00PM ET

1.45

0.00 0.00 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: VRTX REGN AMGN GILD BMRN ALNY BIIB INCY EXEL NBIX

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.34	Insider Own	54.81%	Shs Outstand	34.38M	Perf Week	5.84%
Market Cap	49.85M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	15.54M	Perf Month	27.19%
Enterprise Value	42.56M	PEG	-	EPS next Q	-	Inst Own	6.67%	Short Float	6.69%	Perf Quarter	15.08%
Income	-10.41M	P/S	-	EPS this Y	-	Inst Trans	-0.45%	Short Ratio	10.00	Perf Half Y	-7.64%
Sales	0.00M	P/B	8.43	EPS next Y	-	ROA	-240.34%	Short Interest	1.04M	Perf YTD	9.02%
Book/sh	0.17	P/C	6.84	EPS next 5Y	-	ROE	-317.65%	52W High	3.10 -53.23%	Perf Year	-42.69%
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	-125.22% -189.25%	ROIC	-176.10%	52W Low	1.05 38.10%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.86% 8.07%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	41.45%	Oper. Margin	-	ATR (14)	0.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.14	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	59.92	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.14	EPS Q/Q	38.46%	SMA20	7.01%	Beta	-0.16	Target Price	8.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	10.83%	Rel Volume	1.92	Prev Close	1.45
Employees	2	LT Debt/Eq	0.00	Earnings	-	SMA200	2.41%	Avg Volume	104.02K	Price	1.45
IPO	Feb 09, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	0.00% -	Trades		Volume	199,500	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)